Neurotoxicity of meperidine.
Meperidine neurotoxicity manifests as shakiness, tremors, myoclonus, and seizures. It is generally seen with repeated parenteral use. We report a case of meperidine neurotoxicity from oral use by an otherwise healthy woman. The pharmacology and clinical implications are discussed.
D000284:Administration, Oral; D000328:Adult; D004630:Emergencies; D005260:Female; D006222:Hamartoma / Q000601:surgery; D006801:Humans; D007680:Kidney Neoplasms / Q000601:surgery; D008614:Meperidine / Q000009:adverse effects* / Q000378:metabolism; D009207:Myoclonus / Q000139:chemically induced; D012640:Seizures / Q000139:chemically induced*
D008614:Meperidine